Vattikuti Foundation- AIIMS join hands to offer succour to Parkinson's, essential tremors patients: Our Bureau, Mumbai Friday ...
Implantica receives positive feedback from US FDA for RefluxStop PMA Module 2 submission: Vaduz, Liechtenstein Friday, February 14, 2025, 18:00 Hrs [IST] Implantica AG (publ.), a ...
Rusan Pharma Ltd., is a global leader in pharmaceutical innovation, proudly announces that its chairman, Dr. Navin Saxena, ...
Antengene’s Xpovio approved for reimbursement in Taiwan to treat adult patients with relapsed/refractory multiple myeloma: Shanghai Friday, February 14, 2025, 16:00 Hrs [IST] An ...
Fremont, California Friday, February 14, 2025, 17:00 Hrs [IST] ...
Zydus and Synthon ink exclusive development, licensing & commercialization agreement for a novel 505(B)(2) oncology product for US market: Our Bureau, Mumbai Friday, February 14, ...
Pratteln, Switzerland Friday, February 14, 2025, 15:00 Hrs [IST] ...
Roche’s Evrysdi tablet receives US FDA approval for the treatment of spinal muscular atrophy: Basel Friday, February 14, 2025, 13:00 Hrs [IST] Roche, announced that the US Food ...
US FDA approves expanded label for Astellas’ Izervay for the treatment of geographic atrophy: Tokyo Friday, February 14, 2025, 09:00 Hrs [IST] Astellas Pharma Inc., a global lif ...
Pharmexcil invites member companies to supply API and raw material to Venezuela: Shardul Nautiyal, Mumbai Friday, February 14, 2025, 08:00 Hrs [IST] The Pharmaceuticals Export Pro ...
Pfizer’s Adcetris combination regimen gets US FDA approval to treat relapsed/refractory diffuse large B-cell lymphoma: New York Friday, February 14, 2025, 11:00 Hrs [IST] Pfizer ...
Our Bureau, Mumbai Friday, February 14, 2025, 11:30 Hrs [IST] Health Foods & Dietary Supplements Association (HADSA) will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback